These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12691469)

  • 1. Development of a hepatitis C virus vaccine.
    Inchauspé G; Feinstone S
    Clin Liver Dis; 2003 Feb; 7(1):243-59, xi. PubMed ID: 12691469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for a vaccine against the hepatitis C virus.
    Houghton M; Abrignani S
    Nature; 2005 Aug; 436(7053):961-6. PubMed ID: 16107836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice.
    Gummow J; Li Y; Yu W; Garrod T; Wijesundara D; Brennan AJ; Mullick R; Voskoboinik I; Grubor-Bauk B; Gowans EJ
    J Virol; 2015 Aug; 89(15):7991-8002. PubMed ID: 26018154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete definition of immunological correlates of protection and clearance of hepatitis C virus infection: a relevant pending task for vaccine development.
    Alvarez-Lajonchere L; Dueñas-Carrera S
    Int Rev Immunol; 2012 Jun; 31(3):223-42. PubMed ID: 22587022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses.
    Houghton M
    Immunol Rev; 2011 Jan; 239(1):99-108. PubMed ID: 21198667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA vaccines for hepatitis C virus.
    Brinster C; Inchauspé G
    Intervirology; 2001; 44(2-3):143-53. PubMed ID: 11509875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatitis C vaccine. Current status].
    Forns X
    Gastroenterol Hepatol; 1996; 19(6):317-9. PubMed ID: 8754421
    [No Abstract]   [Full Text] [Related]  

  • 8. Advances in hepatitis C virus vaccines, part two: advances in hepatitis C virus vaccine formulations and modalities.
    Roohvand F; Kossari N
    Expert Opin Ther Pat; 2012 Apr; 22(4):391-415. PubMed ID: 22455502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priming with two DNA vaccines expressing hepatitis C virus NS3 protein targeting dendritic cells elicits superior heterologous protective potential in mice.
    Guan J; Deng Y; Chen H; Yin X; Yang Y; Tan W
    Arch Virol; 2015 Oct; 160(10):2517-24. PubMed ID: 26215441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoprophylaxis of hepatitis C virus infection.
    Prince AM; Shata MT
    Clin Liver Dis; 2001 Nov; 5(4):1091-103. PubMed ID: 11685797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives: towards a peptide-based vaccine against hepatitis C virus.
    Hunziker IP; Zurbriggen R; Glueck R; Engler OB; Reichen J; Dai WJ; Pichler WJ; Cerny A
    Mol Immunol; 2001 Dec; 38(6):475-84. PubMed ID: 11741697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene vaccination for hepatitis C.
    Inchauspé G
    Springer Semin Immunopathol; 1997; 19(2):211-21. PubMed ID: 9406347
    [No Abstract]   [Full Text] [Related]  

  • 13. Preclinical evaluation of multi antigenic HCV DNA vaccine for the prevention of Hepatitis C virus infection.
    Lee H; Jeong M; Oh J; Cho Y; Shen X; Stone J; Yan J; Rothkopf Z; Khan AS; Cho BM; Park YK; Weiner DB; Son WC; Maslow JN
    Sci Rep; 2017 Mar; 7():43531. PubMed ID: 28266565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies and prospects for vaccination against the hepatitis C viruses.
    Houghton M
    Curr Top Microbiol Immunol; 2000; 242():327-39. PubMed ID: 10592667
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies of hepatitis C virus in chimpanzees and their importance for vaccine development.
    Bukh J; Forns X; Emerson SU; Purcell RH
    Intervirology; 2001; 44(2-3):132-42. PubMed ID: 11509874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Induction of cytotoxic T cell responses in mice by immunization with multi-CTL epitope-based anti-HCV DNA vaccine].
    Shi L; Liu S; Sheng L; Meng ZJ; Yuan YK
    Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):385-6. PubMed ID: 16732921
    [No Abstract]   [Full Text] [Related]  

  • 17. Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model.
    El-Gogo S; Staib C; Lasarte JJ; Sutter G; Adler H
    J Gene Med; 2008 Feb; 10(2):177-86. PubMed ID: 18076128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Construction and evaluation of hepatitis C virus (HCV) DNA vaccine containing E2-gAD fusion gene].
    Wen B; Deng Y; Tan WJ; Ying X; Gao JM; Ruan L
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb; 24(1):53-5. PubMed ID: 20848852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG.
    Logan M; Law J; Wong JAJ; Hockman D; Landi A; Chen C; Crawford K; Kundu J; Baldwin L; Johnson J; Dahiya A; LaChance G; Marcotrigiano J; Law M; Foung S; Tyrrell L; Houghton M
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a plant-derived subunit vaccine candidate against hepatitis C virus.
    Nemchinov LG; Liang TJ; Rifaat MM; Mazyad HM; Hadidi A; Keith JM
    Arch Virol; 2000; 145(12):2557-73. PubMed ID: 11205105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.